This week is Patient Safety Awareness Week, hosted by the National Patient Safety Foundation. At Verde, we’re committed to helping health organizations keep patients safe by preventing prescription drug abuse and misuse with the Deterra Drug Deactivation System.
Timed to coincide with National Patient Safety Week, Mallinckrodt Pharmaceuticals announced that it will donate over 120,000 Deterra, formerly known as Medsaway®, medication deactivation pouches to healthcare providers to provide patients a safe, convenient and environmentally friendly way to dispose of unused medications at home.
Did you know?
- In 2013, of the 43,982 drug overdose deaths in the United States, 22,767 (51.8 percent) were related to pharmaceuticals.
- More people die from overdose of prescription drugs than they do from heroin and cocaine combined.
- Among children under age 6, pharmaceuticals account for about 40 percent of all exposures reported to poison centers.
- The Office of National Drug Control Policy’s 2011 Prescription Drug Abuse Plan includes “proper medication disposal” as one of four major action areas to reduce prescription drug abuse.
- In the United States, prescription opioid abuse costs were about $55.7 billion in 2007. Of this amount, 46 percent was attributable to workplace costs (e.g., lost productivity), 45 percent to healthcare costs (e.g., abuse treatment), and 9 percent to criminal justice costs.
How can you get involved?
A new Deterra partnership program is available for companies and advocacy groups, such as manufacturers, payers and health insurance companies, pharmacies, hospitals and surgery centers, community organizations and police departments. The Deterra partnership program provides a cost-effective, environmentally and socially responsible way to quell the urgent issue through distribution of the Deterra System pouches at physician offices, pharmacies, hospitals and community locations to safely dispose of unused and unwanted medications.
Contact us for more information.